Central serous chorioretinopathy following ingestion of sympathomimetics: A case report from Abuja, Nigeria

Abstract

Central serous chorioretinopathy (CSCR) manifests mainly with the buildup of fluids beneath the retina often leading to distorted vision. This case report describes a patient with CSCR. A 34-year-old man presented to the eye clinic in October 2019 with complaints of blurry vision and metamorphopsia, which got worsened after 5 months of no treatment. The patient had a history of intake of a mixture containing phenylephrine, pseudoephedrine, and ephedrine over a period of 3 years for recurrent cold. Upon examination, his visual acuity was RE 6/9 LE 6/7.5 and his left macula was seen having a round serous detachment with creamy-white subretinal deposits. Optical coherence tomography revealed a retinal thickness of 360.5 ± 94.7 µm and macular edema. He was treated with intravitreal ranibizumab and cessation of sympathomimetic drugs with a modest visual improvement achieved within a month. There has been no reoccurrence over the 2-year period he was followed up. There could be an association between chronic ingestion of sympathomimetics and the risk of developing CSCR.